Similar articles

• [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis].

  Kleinert S, Krueger K. Kleinert S, et al. Z Rheumatol. 2011 Aug;70(6):464-72. doi: 10.1007/s00393-011-0755-0. Z Rheumatol. 2011. PMID: 21863467 Review. German.
• [Comorbidity in rheumatic diseases. Check the heart and kidneys of your arthritis patient!].

  Bischoff M. Bischoff M. MMW Fortschr Med. 2014 Nov 20;156(20):30, 32. MMW Fortschr Med. 2014. PMID: 25543360 German. No abstract available.
• Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.

  Mroczkowski PJ, Weinblatt ME, Kremer JM. Mroczkowski PJ, et al. Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S66-8. Clin Exp Rheumatol. 1999. PMID: 10589360 Clinical Trial.
• [Anakinra for therapy of rheumatoid arthritis].

  Tomoo T, Sumida T. Tomoo T, et al. Nihon Rinsho. 2005 Jan;63 Suppl 1:534-7. Nihon Rinsho. 2005. PMID: 15799413 Review. Japanese. No abstract available.
• Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors.

  Naniwa T, Iwagaitsu S, Kajiura M. Naniwa T, et al. Int J Rheum Dis. 2018 Mar;21(3):673-687. doi: 10.1111/1756-185X.13248. Epub 2018 Jan 4. Int J Rheum Dis. 2018. PMID: 29314738